Glass’s excellent barrier properties and regulatory ease make it the first choice for drug manufacturers, but polymer’s stability and inert properties, as well as its wide design options, make it an attractive choice as well.
To find out what works best, together with the drug maker SCHOTT’s experts examine the intended use of a drug and the filling process. During this process they consider the three Ps — product, process, and patient — as a best practice: Does the drug require particularly inert packaging materials? How important are design flexibility, tighter tolerances, and superior break resistance? Do we have to consider integration with safety devices or autoinjectors? Does the packaging have to be compatible with different filling machines and ensure easy regulatory pathways for drug approval? And, most importantly, have we considered patient comfort and needs appropriately?
